---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-021075"
form_type: "8-K"
ticker: "AGL"
cik: "0001831097"
company_name: "agilon health, inc."
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T19:54:21.721746+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# agilon health Q1 revenue up 52% to $1.6B, net loss $6M; lowers FY2024 member & revenue guidance

## Summary
- Revenue $1.60B (+52% YoY); net loss of $6M vs net income $16M in Q1 2023.
- Medical margin $157M (flat YoY); adjusted EBITDA $29M (+21%).
- MA membership 523k (+43%), total platform members 654k.
- Full-year guidance: MA members lowered to 510-515k; revenue lowered to $6.125-6.175B; medical margin & adj. EBITDA unchanged.
- Announced 5 new physician partnerships for Class of 2025, adding 60k+ MA members.

## SEC filing metadata
- accession: 0001628280-24-021075
- form_type: 8-K
- ticker: AGL
- cik: 0001831097
- company_name: agilon health, inc.
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831097/000162828024021075/0001628280-24-021075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831097/000162828024021075/agl-20240507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-021075
- JSON: https://secwatch.observer/filing/0001628280-24-021075.json
- Plain text: https://secwatch.observer/filing/0001628280-24-021075.txt

## Key facts
- Earnings Releases
  agilon health, inc. updated its the first quarter ended March 31, 2024 guidance (reaffirmed).
  - Period: the first quarter ended March 31, 2024
  - Guidance: reaffirmed
  - Result: reported results
  source text: On May 7, 2024 , agilon health, inc. (the “Company”), a Delaware corporation, issued a press release setting forth its financial results for the three months ended March 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831097/000162828024021075/0001628280-24-021075-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.